- Home
- ELVN vs ATAT Comparison
ELVN vs ATAT Comparison
Compare ELVN & ATAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVN | ATAT |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.3B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ELVN | ATAT |
|---|---|---|
| Price | $46.01 | $32.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $43.40 | ★ $49.00 |
| AVG Volume (30 Days) | ★ 1.1M | 661.2K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 2.06% |
| EPS Growth | ★ 3.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $25.48 |
| Revenue Next Year | N/A | $18.11 |
| P/E Ratio | ★ N/A | $26.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.79 | $30.78 |
| 52 Week High | $62.32 | $43.17 |
Technical Indicators
Market Signals| Indicator | ELVN | ATAT |
|---|---|---|
| Relative Strength Index (RSI) | 29.40 | 47.38 |
| Support Level | $25.63 | $31.00 |
| Resistance Level | $48.53 | $33.38 |
| Average True Range (ATR) | 2.30 | 0.85 |
| MACD | -0.93 | 0.01 |
| Stochastic Oscillator | 15.43 | 70.56 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About ATAT Atour Lifestyle Holdings Limited
Atour Lifestyle Holdings Ltd is an upper-midscale hotel chain in China. The company derives revenues from franchise and management fees from its manachised hotels and sales of hotel supplies to manachised hotels, Operations of leased hotels, and sales of retail products. The company has one operating segment, which is the Atour Group.